Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 Amended and Restated Certificate of Incorporation of the Company
- 3.3 Amended and Restated Bylaws of the Company
- 4.3 Warrant to Purchase Common Stock Issued to Keelin Reeds
- 4.4 Form of Warrant to Purchase Common Stock
- 4.5 Form of Warrant to Purchase Preferred Stock
- 4.6 Form of Convertible Unsecured Promissory Note
- 4.7 Form of Convertible Unsecured Promissory Note
- 10.1 Second Amended and Restated Investor Rights Agreement
- 10.2 the April 2011 Purchase Agreement
- 10.4 the October 2011 Purchase Agreement
- 10.5 Form of Indemnification Agreement
- 10.6 Employment Agreement - Donald J. Santel
- 10.7 Offer Letter Agreement - Jeffrey Farrow
- 10.8 Offer Letter Agreement - Bruce F. Scharschmidt, M.D.
- 10.9 Offer Letter Agreement - Klara A. Dickinson
- 10.10 Offer Letter Agreement - Christine A. Nash
- 10.11 Form of Executive Change of Control and Severance Agreement
- 10.12 2006 Equity Incentive Plan, As Amended
- 10.13 2006 Equity Incentive Plan Amendment
- 10.14 Form of Option Agreement Under 2006 Equity Incentive Plan
- 10.18 Office Lease
- 10.19 First Amendment to Office Lease
- 21.1 Subsidiaries of the Company
- 23.1 Consent of Pricewaterhousecoopers LLP
HPTX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1 of our report dated April 13, 2012 relating to the consolidated financial statements of Hyperion Therapeutics, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
San Jose, California
April 13, 2012